Closed
Save

Whole Exome Analysis of Clinical Center Patients

Health & Human Services (HHS) > NIHSol: 75N98026Q00677
FFP
est. $50K – $150K

This opportunity is closed

The response deadline has passed. Review the details for future reference or to track similar opportunities.

Quick Brief

The Department of Health and Human Services is procuring whole exome analysis for the NIAAA Clinical Center patient cohort. The project requires the use of the AmpliSeq Exome enrichment system and ION sequencing platform to maintain analytical integrity across samples. The goal is to identify underlying causes of alcohol related disorders through high throughput genome-wide analysis.

Generated 31d ago

Scope & Requirements

Perform whole exome genome-wide analysis on NIAAA Clinical Center patients using the AmpliSeq Exome enrichment system and ION sequencing platform.

Deliverables

  • Whole exome analysis data

Contract Details

Contract Typei
FFP
Estimated Value
est. $50K – $150K
Similar contracts award $15K to $88K (median $25K, 1,242 awards)Above typical range
Incumbent Contractor
LIFETECHNOLOGIES INC
NAICS Codes
Place of Performance
BETHESDA, MD, USA

Agency & Contact

Contracting Organization

Agency
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-Agency
NATIONAL INSTITUTES OF HEALTH - DRUGS AND BIOLOGICALS

Point of Contact

John A. Smith
Contracting Officer
(202) 555-0100

Key Dates

Published1mo ago
Jun 22, 2026
Became Solicitation1mo ago
Jun 23, 2026
Tracked
Last Updated1mo ago
Jun 24, 2026
Response Date23d ago
Jul 2, 20269:00 AM EDT
Response Due22d ago
Jul 2, 2026

Description

The NIAAA Clinical Center patient cohort has been analyzed patients for sequence variant differences, and changes in response to treatment over the course of many years as part of an effort to identify underlying causes of alcohol related disorders. Analysis has previously been performed on over 2000 patients using the AmpliSeq Exome enrichment system and sequenced on the ION sequencing platform because it provides the capability of cost-effective high throughput whole-exome genome-wide analysis. The use of a single enrichment and sequencing platform with consistent information content is essential for analysis of samples screened at different times and it is therefore imperative for analytical integrity that all samples in the study are processed on the same sequencing platform, as each platform has a unique pattern of error Vishnuvajjala Hanumanth Rao Contracting ., SUITE 503L (No Street Address

2) BETHESDA, MD 20892 USA to this opportunity.

Get matched to contracts like this daily

Free AI-powered contract matching for your business.